The Practical Guidance July 2026 updates add new practice notes, templates, checklists, task maps, resource kits, surveys, Q&As, and legal development content across a broad set of practice areas....
Document automation for law firms is becoming a critical part of modern legal practice. As attorneys face increasing pressure to improve efficiency while maintaining accuracy, legal document automation...
Due to the complexity of U.S. tax law, even the most experienced practitioners require sophisticated tools to resolve client issues. The Internal Revenue Code has now grown to approximately 4.2 million...
June 2026 Brings Expanded Task Maps, State-Specific Guidance, and Practical Resources Across Legal Workflows The June 2026 release of Practical Guidance introduces one of the year's most comprehensive...
Practical Guidance continues to expand its collection of attorney-authored resources with new trackers, task maps, practice notes, templates, checklists, and state-specific guidance designed to support...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
This practice note helps attorneys representing drug and medical device manufacturers advise their clients about liability risks associated with their products, by summarizing the legal landscape surrounding FDCA-based failure-to-warn claims, providing a state-by-state analysis of related common-law duties, and identifying states that recognize FDCA-based failure-to-report claims as a cause of action along with practical insights into the case law of those that do not.
Read now »
Related Content
Practical Guidance Updates Featuring the latest updates from your Practical Guidance account.
PRACTICAL GUIDANCE CUSTOMER EMAIL EDITION ON THE WEB
Experience results today with practical guidance, legal research, and data-driven insights—all in one place.Experience Lexis+